2022-137-E-Health-Duke University - Charlene Wong-Federal awarding agency

Browse Search

21 | Page MY2 at a later date, and no earlier than 2023. Recipients shall submit source data for CDF-CH in MY3 and may be required to do so for a subset of the remaining clinical care measures each year going forward. All measures data are submitted through the RF. C. Out -of-home placement (OOHP). Reducing the rate of out-of-home placement is a primary focus area for the InCK Model and each Recipient is expected to participate in the data reporting and measure development process for a measure to track OOHP as part of model participation. Once defined, CMS will incorporate the OOHP measure into the list of Performance Measure Milestones in a future Budget Period, as early as Budget Period 4. The timing of the OOHP measure’s development is dependent on CMS’s contractor gaining access to the necessary Core Child Services data elements from Recipients. 17. Qualitative Data. The Recipient shall ensure that all the Partnership Council members participate in qualitative data collection activities pertaining to this model. When re quested by CMS, and for the duration of the project period, the Recipient and its partners shall assist the model evaluation contractor with the acquisition of qualitative data. Dat a collection activities that may require the Recipient and its partners to cooperate or participate in include, but are not limited to, arranging and granting interviews; assisting in recruiting for focus groups and individual interviews with model-associated staff, beneficiaries, and beneficiary caregivers; allowing observations of any model-funded activities; providing agendas, notes and/or minutes from Partnership Council meetings; providing program documents such as patient education and staff training materials; surveys of staff and/or beneficiary families; and any other necessary activities. 18. Evaluation. CMS conducts the InCK Model evaluation with the assistance of an independent contractor , Abt Associates (“Abt”). Abt is CMS’s business associate under the HIPAA Privacy Rule. The Recipient is an “entity participating” in the testing of a model under Section 1115A of the Act, and, as such, is required by 42 CFR § 403.1110(b) to collect and report such data as may be required by CMS, or its contractor (s), to carry out model evaluation. This includ es personally identifiable information (PII), even if such data qualifies as protected health information (PHI) as that term is defined at 45 CFR § 160.103. Recipients shall submit both PII and PHI into CMS patient-protected systems . In addition, as a condition of receiving award funds, the Recipient is responsible for requiring and ensuring participation in the model evaluation by all Model Partners (including contractors , consultants and subrecipients) and InCK -attributed beneficiaries. See NOFO Section F5.2, Evaluation. The Recipient shall enter sub-award agreements with its subrecipients. Such sub-award agreements must expressly note that the acceptance of award funds will also make the subrecipient an “entity participating” in a section 1115A model, and, as such, will render subrecipients also subject to 42 CFR sec. 403.1110(b). DocuSign Envelope ID: 7832B0E4-F34E-430E-A3C2-1A6A14F29307